Industry expert's new report, “” provides key data, information and analysis on the global glucose monitoring systems industry . The report provides industry landscape, competitive landscape and industry trends data on the glucose monitoring systems industry . The report provides comprehensive data on the major industry developments affecting the industry, and key analytical content on the industry dynamics. The report also reviews the competitive landscape and technology offerings.

Scope of the Research

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key sectors covered include blood glucose meters, blood glucose test strips, and lancets.
- Annualized industry revenues data from 2002 to 2009, projection forward for 7 years to 2016. Firms shares data for 2009.
- Qualitative analysis of key industry trends, industry drivers, and restraints by each category within glucose monitoring systems industry .
- The report also covers data on the leading industry players, the competitive landscape, and the leading new product development and technologies.
- Key Companies covered include LifeScan, Inc., F. Hoffmann-La Roche Ltd., Bayer HealthCare AG, and Abbott Laboratories.

Why Should You Get This Report?

- Develop business strategies by understanding the trends and developments that are driving the glucose monitoring systems industry globally.
- Design and develop your product development, industry ing and sales strategies.
- Develop successful market-entry strategies .
- Identify key players best positioned to take advantage of the emerging industry opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next big thing in the glucose monitoring systems industry landscape? – Identify, understand and decide.
- Make more informed business decisions from the insightful and in-depth analysis of the global glucose monitoring systems industry and the factors shaping it.

Table Of Contents

1 Table of contents 2
I. 1 List of Data tables 4
I. 2 List of Charts 5

II Introduction 6
II. 1 GlobalData Report Guidance 6
3 Disease Data 7
III. 1 Diabetes 7
III. 2 Epidemiology 7

IV Glucose Monitoring Devices Overview 9
IV. 1 Glucose Monitoring Devices 9
5 World Glucose Monitoring Devices: March ket Characterization 10
V. 1 Glucose Monitoring Devices March ket, Global, Sales ($bn), Historical data, 2002-2009 10
V. 2 Glucose Monitoring Devices March ket, Global, Sales ($bn), Forecasted data, 2009-2016 11
V. 3 Glucose Monitoring Devices, March ket Dynamics 12
V. 3.1 Glucose Monitoring Devices, March ket Drivers 12
V. 3.2 Glucose Monitoring Devices, March ket Restraints 14
V. 4 Opportunities and Unmet Needs 15
6 World Glucose Monitoring Devices March ket, Sales (USD Million), By Country, 2002-2016 16
VI. 1 Glucose Monitoring Devices March ket, US, Sales ($bn), Historical data, 2002-2009 16
VI. 2 Glucose Monitoring Devices March ket, US, Sales ($bn), Forecasted data, 2009-2016 17
VI. 3 Glucose Monitoring Devices March ket, Canada, Sales (USD Million), Historical data, 2002-2009 18
VI. 4 Glucose Monitoring Devices March ket, Canada, Sales (USD Million), Forecasted data, 2009-2016 19
VI. 5 Glucose Monitoring Devices March ket, Germany, Sales (USD Million), Historical data, 2002-2009 20
VI. 6 Glucose Monitoring Devices March ket, Germany, Sales (USD Million), Forecasted data, 2009-2016 21
VI. 7 Glucose Monitoring Devices March ket, France, Sales (USD Million), Historical data, 2002-2009 22
VI. 8 Glucose Monitoring Devices March ket, France, Sales (USD Million), Forecasted data, 2009-2016 23
VI. 9 Glucose Monitoring Devices March ket, UK, Sales (USD Million), Historical data, 2002-2009 24
VI. 10 Glucose Monitoring Devices March ket, UK, Sales (USD Million), Forecasted data, 2009-2016 25
VI. 11 Glucose Monitoring Devices March ket, Italy, Sales (USD Million), Historical data, 2002-2009 26
VI. 12 Glucose Monitoring Devices March ket, Italy, Sales (USD Million), Forecasted data, 2009-2016 27
VI. 13 Glucose Monitoring Devices March ket, Spain, Sales (USD Million), Historical data, 2002-2009 28
VI. 14 Glucose Monitoring Devices March ket, Spain, Sales (USD Million), Forecasted data, 2009-2016 29
VI. 15 Glucose Monitoring Devices March ket, Japan, Sales (USD Million), Historical data, 2002-2009 30
VI. 16 Glucose Monitoring Devices March ket, Japan, Sales (USD Million), Forecasted data, 2009-2016 31
VI. 17 Glucose Monitoring Devices March ket, China, Sales (USD Million), Historical data, 2002-2009 32
VI. 18 Glucose Monitoring Devices March ket, China, Sales (USD Million), Forecasted data, 2009-2016 33
VI. 19 Glucose Monitoring Devices March ket, India, Sales (USD Million), Historical data, 2002-2009 34
VI. 20 Glucose Monitoring Devices March ket, India, Sales (USD Million), Forecasted data, 2009-2016 35
VI. 21 Glucose Monitoring Devices March ket, Australia, Sales (USD Million), Historical data, 2002-2009 36
VI. 22 Glucose Monitoring Devices March ket, Australia, Sales (USD Million), Forecasted data, 2009-2016 37
VI. 23 Glucose Monitoring Devices March ket, Brazil, Sales (USD Million), Historical data, 2002-2009 38
VI. 24 Glucose Monitoring Devices March ket, Brazil, Sales (USD Million), Forecasted data, 2009-2016 39
7 World Glucose Monitoring Devices March ket: Competitive Assessment 40
VII. 1 Glucose Monitoring Devices March ket, Key Market Shares (%), 2009 40
VII. 2 Glucose Monitoring Devices March ket, Key March ket Participants Presence, by Sector 41
VII. 2.1 LifeScan, Inc. 41
VII. 2.2 F. Hoffmann-La Roche Ltd. 42
VII. 2.3 Bayer Healthcare 43
VII. 2.4 Abbott Laboratories 43
VII. 2.5 Arkray, Inc. 44

VIII Key Glucose Monitoring Devices in the March ket 45
VIII. 1 Accu-Check Aviva (F. Hoffmann-La Roche Ltd.) 45
VIII. 1.1 Overview 45
VIII. 1.2 Features and Benefits 45
VIII. 1.3 Clinical Trial Details 46
VIII. 2 OneTouch Ultramini (LifeScan, Inc.) 46
VIII. 2.1 Overview 46
VIII. 2.2 Features and Benefits 46
VIII. 3 Contour Meter (Bayer Healthcare) 47
VIII. 3.1 Overview 47
VIII. 3.2 Features and Benefits 47

IX Glucose Monitoring Devices March ket, Pipeline Assessment 48
IX. 1 Pipeline Technology Assessment for Glucose Monitoring Devices, World 49
IX. 2 Profiles of Promising Glucose Monitoring Devices Under Clinical Development 52
IX. 2.1 Breath-Based Blood Glucose Monitor 52
IX. 2.2 Easy Check Breath Glucose Detection System 52
IX. 2.3 I-SugarX 52
IX. 2.4 GlucoTrack 53
IX. 2.5 LighTouch Monitor 53
IX. 2.6 Glucose Pop Test Device 53
IX. 2.7 Biomonitoring System 54
IX. 2.8 GLUCOCARD II DATA GT-1650 54
IX. 2.9 Accu-Chek Combo 55
IX. 2.10 ACCU-Chek Inform II with RALS-Plus Data Management System 55

X Global Insulin Delivery Devices March ket: Strategic Deals Analysis 58
X. 1 Key Deals 58
X. 1.1 Luminous Medical Enters into Agreement with a Supplier of Electrochemical Sensors 58
X. 1.2 Arkray Signs Distribution Agreement with Nipro 58
X. 1.3 Ypsomed Holding Takes Over 10% Equity Stake in BIONIME 58
X. 1.4 Mankind Pharma Enters into an Agreement with Roche Diagnostics 58
X. 1.5 Mediscience Technology Takes Over SensiVida Medical Systems 59

XI Appendix 60
XI. 1 Definitions 60
XI. 1.1 Glucose Monitoring Devices 60
XI. 2 Acronyms 61
XI. 3 Sources 61
XI. 4 Research Methodology 62
XI. 5 Secondary Research 62
XI. 6 Primary Research 63
XI. 7 Models 63
XI. 8 Forecasted data s 63
XI. 9 Expert Panels 64
XI. 10 GlobalData Consulting 64
XI. 11 Contact Us 64
XI. 12 Disclaimer 64

1.1 List of Data tables

Data table 1: Diabetes, Estimated Prevalence (millions), by Country, 2010 and 2030 8
Data table 2: Glucose Monitoring Devices March ket, Global, Sales ($bn), 2002-2009 10
Data table 3: Glucose Monitoring Devices March ket, Global, Sales ($bn), 2009-2016 11
Data table 4: Glucose Monitoring Devices March ket, US, Sales ($bn), 2002-2009 16
Data table 5: Glucose Monitoring Devices March ket, US, Sales ($bn), 2009-2016 17
Data table 6: Glucose Monitoring Devices March ket, Canada, Sales (USD Million), 2002-2009 18
Data table 7: Glucose Monitoring Devices March ket, Canada, Sales (USD Million), 2009-2016 19
Data table 8: Glucose Monitoring Devices March ket, Germany, Sales (USD Million), 2002-2009 20
Data table 9: Glucose Monitoring Devices March ket, Germany, Sales (USD Million), 2009-2016 21
Data table 10: Glucose Monitoring Devices March ket, France, Sales (USD Million), 2002-2009 22
Data table 11: Glucose Monitoring Devices March ket, France, Sales (USD Million), 2009-2016 23
Data table 12: Glucose Monitoring Devices March ket, UK, Sales (USD Million), 2002-2009 24
Data table 13: Glucose Monitoring Devices March ket, UK, Sales (USD Million), 2009-2016 25
Data table 14: Glucose Monitoring Devices March ket, Italy, Sales (USD Million), 2002-2009 26
Data table 15: Glucose Monitoring Devices March ket, Italy, Sales (USD Million), 2009-2016 27
Data table 16: Glucose Monitoring Devices March ket, Spain, Sales (USD Million), 2002-2009 28
Data table 17: Glucose Monitoring Devices March ket, Spain, Sales (USD Million), 2009-2016 29
Data table 18: Glucose Monitoring Devices March ket, Japan, Sales (USD Million), 2002-2009 30
Data table 19: Glucose Monitoring Devices March ket, Japan, Sales (USD Million), 2009-2016 31
Data table 20: Glucose Monitoring Devices March ket, China, Sales (USD Million), 2002-2009 32
Data table 21: Glucose Monitoring Devices March ket, China, Sales (USD Million), 2009-2016 33
Data table 22: Glucose Monitoring Devices March ket, India, Sales (USD Million), 2002-2009 34
Data table 23: Glucose Monitoring Devices March ket, India, Sales (USD Million), 2009-2016 35
Data table 24: Glucose Monitoring Devices March ket, Australia, Sales (USD Million), 2002-2009 36
Data table 25: Glucose Monitoring Devices March ket, Australia, Sales (USD Million), 2009-2016 37
Data table 26: Glucose Monitoring Devices March ket, Brazil, Sales (USD Million), 2002-2009 38
Data table 27: Glucose Monitoring Devices March ket, Brazil, Sales (USD Million), 2009-2016 39
Data table 28: LifeScan, Inc., March keted Products, 2010 41
Data table 29: LifeScan, Inc. Pipeline Products, 2010 42
Data table 30: Hoffmann-La Roche Ltd., March keted Products, 2010 42
Data table 31: Hoffmann-La Roche Ltd., Pipeline Products, 2010 42
Data table 32: Bayer HealthCare AG, March keted Products, 2010 43
Data table 33: Abbott, March keted Products, 2010 43
Data table 34: Arkray, March keted Products, 2010 44
Data table 35: Arkray, Pipeline Products, 2010 44
Data table 36: Accu-Check Aviva, Features and Benefits 45
Data table 37: OneTouch Ultra Mini, Features and Benefits 46
Data table 38: Contour Meter, Features and Benefits 47
Data table 39: World Glucose Monitoring Devices March ket, Pipeline by Sector, 2010 48
Data table 40: Pipeline Technology Assessment for Glucose Monitoring Devices by Development Stage, Global, 2010 49
Data table 41: Breath-Based Blood Glucose Monitor, Product Status, 2010 52
Data table 42: Easy Check Breath Glucose Detection System, Product Status, 2010 52
Data table 43: I-SugarX, Product Status, 2010 52
Data table 44: GlucoTrack, Product Status, 2010 53
Data table 45: LighTouch Monitor, Product Status, 2010 53
Data table 46: Glucose Pop Test Device, Product Status, 2010 54
Data table 47: Biomonitoring System, Product Status, 2010 54
Data table 48: GLUCOCARD II DATA GT-1650, Product Status, 2010 55
Data table 49: Accu-Chek Combo, Product Status, 2010 55
Data table 50: Accu-Chek Inform II with RALS-Plus Data Management System, Product Status, 2010 55
Data table 51: Glucose Monitoring Devices, Pipeline Summary, 2010 56
Data table 52: Glucose Monitoring Devices, Pipeline Summary, 2010 57

1.2 List of Charts

Chart 1: Diabetes, Estimated Prevalence (millions), by Country, 2010 and 2030 7
Chart 2: Glucose Monitoring Devices, March ket Segments 9
Chart 3: Glucose Monitoring Devices March ket, Global, Sales ($bn), 2002-2009 10
Chart 4: Glucose Monitoring Devices March ket, Global, Sales ($bn), 2009-2016 11
Chart 5: Glucose Monitoring Devices March ket, Drivers and Restraints 12
Chart 6: Glucose Monitoring Devices March ket, US, Sales ($bn), 2002-2009 16
Chart 7: Glucose Monitoring Devices March ket, US, Sales ($bn), 2009-2016 17
Chart 8: Glucose Monitoring Devices March ket, Canada, Sales (USD Million), 2002-2009 18
Chart 9: Glucose Monitoring Devices March ket, Canada, Sales (USD Million), 2009-2016 19
Chart 10: Glucose Monitoring Devices March ket, Germany, Sales (USD Million), 2002-2009 20
Chart 11: Glucose Monitoring Devices March ket, Germany, Sales (USD Million), 2009-2016 21
Chart 12: Glucose Monitoring Devices March ket, France, Sales (USD Million), 2002-2009 22
Chart 13: Glucose Monitoring Devices March ket, France, Sales (USD Million), 2009-2016 23
Chart 14: Glucose Monitoring Devices March ket, UK, Sales (USD Million), 2002-2009 24
Chart 15: Glucose Monitoring Devices March ket, UK, Sales (USD Million), 2009-2016 25
Chart 16: Glucose Monitoring Devices March ket, Italy, Sales (USD Million), 2002-2009 26
Chart 17: Glucose Monitoring Devices March ket, Italy, Sales (USD Million), 2009-2016 27
Chart 18: Glucose Monitoring Devices March ket, Spain, Sales (USD Million), 2002-2009 28
Chart 19: Glucose Monitoring Devices March ket, Spain, Sales (USD Million), 2009-2016 29
Chart 20: Glucose Monitoring Devices March ket, Japan, Sales (USD Million), 2002-2009 30
Chart 21: Glucose Monitoring Devices March ket, Japan, Sales (USD Million), 2009-2016 31
Chart 22: Glucose Monitoring Devices March ket, China, Sales (USD Million), 2002-2009 32
Chart 23: Glucose Monitoring Devices March ket, China, Sales (USD Million), 2009-2016 33
Chart 24: Glucose Monitoring Devices March ket, India, Sales (USD Million), 2002-2009 34
Chart 25: Glucose Monitoring Devices March ket, India, Sales (USD Million), 2009-2016 35
Chart 26: Glucose Monitoring Devices March ket, Australia, Sales (USD Million), 2002-2009 36
Chart 27: Glucose Monitoring Devices March ket, Australia, Sales (USD Million), 2009-2016 37
Chart 28: Glucose Monitoring Devices March ket, Brazil, Sales (USD Million), 2002-2009 38
Chart 29: Glucose Monitoring Devices March ket, Brazil, Sales (USD Million), 2009-2016 39
Chart 30: Glucose Monitoring Devices March ket, Global, Key Market Shares (%), 2009 40
Chart 31: Glucose Monitoring Devices March ket, Presence of Key March ket Participants by Sector, 2010 41
Chart 32: Key Glucose Monitoring Devices in the March ket, 2010 45
Chart 33: World Glucose Monitoring Devices March ket, Pipeline by Sector, 2010 48
Chart 34: Pipeline Technology Assessment for Glucose Monitoring Devices by Development Stage, Global, 2010 49
Chart 35: Pipeline Technology Assessment for Glucose Monitoring Devices by Development Stage, Global, 2010 50
Chart 36: Pipeline Technology Assessment for Glucose Monitoring Devices by Unmet Need, Global, 2010 51

Companies mentioned
LifeScan, Inc.
F. Hoffmann-La Roche Ltd.
Bayer Healthcare
Abbott Laboratories
Arkray, Inc.

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Wound Management Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Wound Management Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • July 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

ATS Automation Tooling Systems Inc. (Symbol:ATA) SWOT Analysis, Strategy, Revenues and Profits

ATS Automation Tooling Systems Inc. (Symbol:ATA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • June 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Terumo Cardiovascular Systems Corporation SWOT Analysis, Strategy, Revenues and Profits

Terumo Cardiovascular Systems Corporation SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • July 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.